Tag: ozone autohemotherapy

A pilot randomized controlled trial of major ozone autohemotherapy for patients with post-acute sequelae of COVID-19

This randomized controlled trial investigated the effects of major ozone autohemotherapy (O₃-MAH) on patients with post-acute sequelae of COVID-19 (PASC). Seventy-three patients were assigned to receive either O₃-MAH plus conventional therapy or conventional therapy alone. The O₃-MAH group showed significantly greater improvements in symptoms, pulmonary function, and inflammatory markers, particularly

Read More »

Cerebrovascular pattern improved by ozone autohemotherapy: an entropy-based study on multiple sclerosis patients

This study explored the effects of ozone autohemotherapy on cerebrovascular function in multiple sclerosis (MS) patients, using entropy-based analysis to assess improvements in blood flow and vascular health. The treatment significantly enhanced cerebral blood flow and cerebrovascular patterns, suggesting its potential to mitigate neurovascular damage and improve neurological health in

Read More »